← All Adagio Medical Holdings, INC filings

Adagio Medical Holdings, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ
ADGM
Adagio Medical Holdings, INC
10-K: Adagio Medical Faces Going Concern Amidst Losses, Advances VT Ablation
Adagio Medical Holdings, Inc. reported recurring net losses and a going concern warning, despite advancing its vCLAS Cryoablation System with Breakthrough Device Designation and positive clinical trial results.
NASDAQ
ADGM
Adagio Medical Holdings, INC
10-K/A: Adagio Medical Holdings Files Amendment No. 1 to Form 10-K, Updating Executive and Governance Information
Adagio Medical Holdings files an amendment to its annual report to include information on directors, executive officers, corporate governance, and updated exhibits.
NASDAQ
ADGM
Adagio Medical Holdings, INC
10-K: Adagio Medical Holdings Reports Fiscal Year 2024 Results, Outlines Strategic Realignment
Adagio Medical Holdings files its 10-K, detailing 2024 financials, a strategic shift towards ventricular tachycardia treatment, and ongoing efforts to secure regulatory approvals.